KMID : 1103920090150030370
|
|
Korean Journal of Hepatology 2009 Volume.15 No. 3 p.370 ~ p.374
|
|
A case of sudden-onset hearing loss in a patient treated with peginterferon ¥á-2b and ribavirin for chronic hepatitis C
|
|
Shin Min-Ki
Kim Tae-Hyo Ju Kang Ha Chang-Yoon Min Hyun-Ju Jung Woon-Tae Lee Ok-Jae
|
|
Abstract
|
|
|
Combination therapy of pegylated interferon ¥á and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset hearing loss during combination therapy with pegylated interferon ¥á and ribavirin for chronic hepatitis C. This patient had been diagnosed with chronic hepatitis C (genotype Ib) and early-stage liver cirrhosis 3 years previously, and had been treated with conventional interferon-¥á and ribavirin for 12 months. However, 6 months from the end of the treatment course the patient relapsed and received combination retreatment with pegylated interferon ¥á-2b and ribavirin. He developed sudden-onset right-side hearing loss and tinnitus 42 weeks after the start of this retreatment. Pure-tone audiometry revealed a right-side hearing loss of 60~90dB. The patient consequently immediately discontinued the pegylated interferon therapy and was given prednisone 60 mg/day for 10 days, after which the hearing loss had almost completely recovered.
|
|
KEYWORD
|
|
Chronic hepatitis C, Peginterferon alfa-2b, Hearing loss, Sudden, Adverse effects
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|